Snape J P, Waldock A
Ophthalmic Outpatients Department, Torbay Hospital, Andrew Waldock, MD, USA.
Nurs Stand. 2000;15(4):35-8. doi: 10.7748/ns2000.10.15.4.35.c2929.
To evaluate the effects of four glaucoma medications on the cardio-respiratory system.
All newly diagnosed glaucoma (primary open-angle glaucoma--POAG--or normal tension glaucoma) patients were recruited into a 12-month prospective audit.
The study has resulted in glaucoma patients having a spirometry lung function test before being prescribed beta-blocker eye drops. The results of this study demonstrate a high level of both systemic and ocular side-effects caused by these topical glaucoma medications.
This study confirms the findings of previous studies, which have shown topical beta-blockers to be harmful to older people with glaucoma and 'hidden' reversible airways disease. It also shows the consequences of using topical beta-blockers on patients who have previously undiagnosed respiratory and cardiac disease.
评估四种青光眼药物对心肺系统的影响。
所有新诊断的青光眼（原发性开角型青光眼——POAG——或正常眼压性青光眼）患者被纳入一项为期12个月的前瞻性审计。
该研究使得青光眼患者在开具β受体阻滞剂眼药水之前进行了肺活量测定肺功能测试。这项研究的结果表明，这些局部用青光眼药物会引起高水平的全身和眼部副作用。
本研究证实了先前研究的结果，这些结果表明局部用β受体阻滞剂对患有青光眼和“隐匿性”可逆性气道疾病的老年人有害。它还显示了对先前未被诊断出患有呼吸系统和心脏疾病的患者使用局部用β受体阻滞剂的后果。
